SAGAWA Takaomi
Department School of Medicine(Tokyo Women's Medical University Hospital), School of Medicine Position Assistant Professor |
|
Article types | Original article |
Language | English |
Peer review | Peer reviewed |
Title | Impact of continued administration of tolvaptan on cirrhotic patients with ascites. |
Journal | Formal name:BMC pharmacology & toxicology Abbreviation:BMC Pharmacol Toxicol ISSN code:(2050-6511)2050-6511(Linking) |
Domestic / Foregin | Foregin |
Volume, Issue, Page | 19(1),pp.87 |
Author and coauthor | KOGISO Tomomi,SAGAWA Takaomi,KODAMA Kazuhisa,TANIAI Makiko,TOKUSHIGE Katsutoshi |
Authorship | 2nd author |
Publication date | 2018/12 |
Summary | Long-term tolvaptan treatment increased serum levels of albumin, decreased ammonia levels, and preserved renal function after 1 year of treatment. A reduction in body weight after 1 week was associated with a favorable outcome of tolvaptan therapy. |
DOI | 10.1186/s40360-018-0277-3 |
PMID | 30563565 |